Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: PTSC Filing Concerning the Indpendent Study on the 250 Billion Market Share - honey

RE: PTSC Filing Concerning the Indpendent Study on the 250 Billion Market Share - honey

posted on Jul 21, 2006 11:30AM
Another reference by the EE times - they (not PTSC, but EE times) came up with $200B.

http://www.eetimes.com/article/showArticle.jhtml?articleId=18309168

Reporters are usually highly inaccurate in their stories, hence not paid alot of money. $500B is more realistic ;-)

(Again, more Kudos to the Tucci page)

Regards

Share
New Message
Please login to post a reply